Combination of an il-1/18 inhibitor with a tnf inhibitor for the treatment of inflammation
CA 2468706 A1 · Owner: Gabel, Christopher Allen · Inventors: Gabel, Christopher Allen; Dombroski, Mark Anthony
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
The invention relates to compositions and methods for treating or preventing inflammation, including rheumatoid arthritis (RA). The method comprises administering to mammals in need thereof an effective amount of a composition containing an agent that inhibits IL-1/18 combination with a TNF inhibitor.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed October 18, 2002. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended October 18, 2022.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by October 18, 2024.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.